High sensitivity LC-MS/MS method for direct quantification of human parathyroid 1-34 (teriparatide) in human plasma

Erin E. Chambers*, Mary E. Lame, Jon Bardsley, Sally Hannam, Cristina Legido-Quigley, Norman Smith, Kenneth J. Fountain, Eileen Collins, Elizabeth Thomas

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)


Teriparatide, the 1-34 fragment of human parathyroid hormone, is used to treat osteoporosis patients with a high risk of fracture by stimulating new bone formation. Routinely teriparatide is quantified using radioimmunoassay however the LC-MS/MS described here has the potential to achieve greater accuracy and precision, higher specificity, and is readily implemented in routine bioanalytical laboratories. Hence a complete method combining effective sample prep with appropriate LC separation and selected reaction monitoring (SRM) MS detection was developed to selectively separate teriparatide from closely related endogenous peptides and to reduce interferences. Samples were concentrated without evaporation, minimizing the risk of adsorptive losses. Chromatography was performed on a sub 2. μm particle charged surface hybrid column, which provided significantly higher peak capacity than a traditional C18 column when formic acid was used as the mobile phase modifier. Total LC cycle time was 6. min. An LOD of 15. pg/mL (3.6. fmol/mL) from 200. μL of human plasma was readily achieved and standard curves were accurate and precise from 15. pg/mL to 500. pg/mL. Mean QC accuracies ranged from 90% to 106%. Mean QC precision was better than 7%. The CV of matrix factors across 6 sources of human plasma was 5%. The assay presented here is the first LC-MS method which reaches clinically relevant detection limits for teriparatide. 

Original languageEnglish
Pages (from-to)96-104
Number of pages9
JournalJournal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences
Publication statusPublished - 1 Nov 2013


  • Bioanalysis
  • Human growth hormone
  • LC-MS/MS peptide quantification
  • RhPTH (1-34)
  • Solid phase extraction (SPE)
  • Teriparatide


Dive into the research topics of 'High sensitivity LC-MS/MS method for direct quantification of human parathyroid 1-34 (teriparatide) in human plasma'. Together they form a unique fingerprint.

Cite this